UCLA conservationists and legal experts said upcoming changes to how the Endangered Species Act is implemented will make it more difficult to protect wildlife from extinction.
Yearlong roadwork on Sunset Boulevard near UCLA might cause travel delays to Westwood, according to a university announcement June 24.
Construction will occur on Sunset Boulevard between the 405 Freeway and Bellagio Road, and between South Beverly Glen Boulevard and Carolwood Drive.
UCLA researchers in the physics and astronomy department published a paper in February claiming stars in the center of the galaxy are rich with metals, offering a potential new theory about the creation of elements in the universe.
UCLA researchers may have discovered the cause of a huge, bow-shaped wave on Venus that has puzzled planetary scientists for years.
Their computer simulations of the Venusian atmosphere showed that wind blowing across mountains creates oscillations of the air, called mountain waves, that launch high into the clouds.
Surgery might have a decadeslong learning curve, according to a UCLA-led study.
Researchers found that patients treated by older surgeons had lower death rates within 30 days of their procedures than those treated by younger surgeons.
UCLA researchers have developed a data-driven method to find hormones that organs and tissues use to communicate with one another.
Using their method, the researchers identified two hormones, NOTUM, secreted from the liver, and Lipocalin-5, secreted from fat tissue, that speed up the metabolism of fat in mice, according to a university press release.
A UCLA alumnus and Nobel laureate shared his latest research on RNA sorting into exosomes at a seminar Wednesday.
More than 250 people packed into an auditorium in Geffen Hall to listen to Randy Schekman, who shared the 2013 Nobel Prize in Physiology or Medicine for discovering a set of genes required for intracellular transportation of molecules in sacs called vesicles.
UCLA Health has received certification to provide a therapy that genetically modifies patients’ own cells to attack cancer, the university announced Friday.
The Food and Drug Administration approved the treatment, marketed as Yescarta, in October for patients with a type of blood cancer called large B cell lymphoma.
searching for more articles...